BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31262358)

  • 1. Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
    Barbati C; Stefanini L; Colasanti T; Cipriano E; Celia A; Gabriele G; Vomero M; Ceccarelli F; Spinelli FR; Finucci A; Speziali M; Orso G; Margiotta DPE; Conti F; Violi F; Afeltra A; Valesini G; Alessandri C
    Arthritis Res Ther; 2019 Jul; 21(1):161. PubMed ID: 31262358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation in patients with antiphospholipid syndrome.
    Shechter Y; Tal Y; Greenberg A; Brenner B
    Blood Coagul Fibrinolysis; 1998 Oct; 9(7):653-7. PubMed ID: 9863715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
    Vega-Ostertag M; Harris EN; Pierangeli SS
    Arthritis Rheum; 2004 Sep; 50(9):2911-9. PubMed ID: 15457460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.
    Patsouras MD; Sikara MP; Grika EP; Moutsopoulos HM; Tzioufas AG; Vlachoyiannopoulos PG
    J Autoimmun; 2015 Dec; 65():30-7. PubMed ID: 26283469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
    Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
    Front Immunol; 2019; 10():773. PubMed ID: 31031764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
    Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
    Front Immunol; 2019; 10():460. PubMed ID: 30923525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
    Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
    Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study.
    Hisada R; Kato M; Sugawara E; Fujieda Y; Oku K; Bohgaki T; Amengual O; Yasuda S; Atsumi T
    J Thromb Haemost; 2017 Sep; 15(9):1782-1787. PubMed ID: 28662299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
    Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric detection of circulating activated platelets in primary antiphospholipid syndrome. Correlation with thrombocytopenia and anticardiolipin antibodies.
    Fanelli A; Bergamini C; Rapi S; Caldini A; Spinelli A; Buggiani A; Emmi L
    Lupus; 1997; 6(3):261-7. PubMed ID: 9104734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS).
    Ceribelli A; Tincani A; Cavazzana I; Franceschini F; Cattaneo R; Pauley BA; Chan JY; Chan EK; Satoh M
    Autoimmunity; 2011 Mar; 44(2):90-7. PubMed ID: 20695766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia.
    Fabris F; Steffan A; Cordiano I; Borzini P; Luzzatto G; Randi ML; Girolami A
    Eur J Haematol; 1994 Oct; 53(4):232-6. PubMed ID: 7957808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial coexistence of primary antiphospholipid syndrome and factor VLeiden.
    Schütt M; Klüter H; Hagedorn-Greiwe M; Fehm HL; Wiedemann GJ
    Lupus; 1998; 7(3):176-82. PubMed ID: 9607641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome: their relationship with the observed thrombocytopenia.
    Macchi L; Rispal P; Clofent-Sanchez G; Pellegrin JL; Nurden P; Leng B; Nurden AT
    Br J Haematol; 1997 Aug; 98(2):336-41. PubMed ID: 9266930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet and endothelial activation in catastrophic and quiescent antiphospholipid syndrome.
    Bontadi A; Ruffatti A; Falcinelli E; Giannini S; Marturano A; Tonello M; Hoxha A; Pengo V; Punzi L; Momi S; Gresele P
    Thromb Haemost; 2013 May; 109(5):901-8. PubMed ID: 23572134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenic role of anti-phosphatidylserine antibodies: active immunization with the antibodies leads to the induction of antiphospholipid syndrome.
    Yodfat O; Blank M; Krause I; Shoenfeld Y
    Clin Immunol Immunopathol; 1996 Jan; 78(1):14-20. PubMed ID: 8599879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation.
    Hisada R; Kato M; Sugawara E; Kanda M; Fujieda Y; Oku K; Bohgaki T; Amengual O; Horita T; Yasuda S; Atsumi T
    J Thromb Haemost; 2019 Jul; 17(7):1134-1143. PubMed ID: 30864219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific antiplatelet glycoprotein autoantibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome.
    Godeau B; Piette JC; Fromont P; Intrator L; Schaeffer A; Bierling P
    Br J Haematol; 1997 Sep; 98(4):873-9. PubMed ID: 9326182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.